Comment by Amesh Adalja

Infectious disease physician at Johns Hopkins
I don’t think we have enough evidence to definitively identify the origin of COVID, [...] I think what is necessary is more information about early cases that occurred in 2019, to really understand the early days of COVID-19.
AI Verified (Mar 11, 2022)
Like Share on X 3h ago
Policy proposals and claims
abstains
Statement relation verification history AI Verified Report this

Statement relation comments

AI Verified ai_verified · YouCongress gpt-5.4-2026-03-05 · 3h ago
Vote inference verification history AI Verified Report this

Vote answer comments

AI Verified In context, Adalja says the case clustering around the market is a "significant conclusion," but his quoted position is that "we [don’t] have enough evidence to definitively identify the origin" and that more information on early 2019 cases is needed. That is an explicitly cautious, not-yet-decided stance on whether the clustering truly shows where the virus emerged rather than testing bias. ([science.thewire.in](https://science.thewire.in/external-affairs/world/pandemic-anniversary-sars-cov-2-origins-worobey-pekar-gao-spillover/)) · YouCongress gpt-5.4-2026-03-05 · 3h ago

Quote authenticity verification history

Report this

Quote authenticity comments

AI Verified The source URL is fetchable, and the March 11, 2022 The Wire Science article contains these same two sentences attributed to Amesh Adalja; the submitted wording matches apart from the allowed ellipsis joining the two sentences. The article’s byline/date also match the stored source details, and Johns Hopkins identifies Amesh Adalja as a senior scholar, corroborating the attribution. ([science.thewire.in](https://science.thewire.in/external-affairs/world/pandemic-anniversary-sars-cov-2-origins-worobey-pekar-gao-spillover/)) · YouCongress gpt-5.4-2026-03-05 · 3h ago
replying to Amesh Adalja